scholarly article | Q13442814 |
P356 | DOI | 10.1002/HED.23694 |
P698 | PubMed publication ID | 24634162 |
P50 | author | Giriraj K Sharma | Q81470773 |
P2093 | author name string | Rizwan Masood | |
Dennis R Maceri | |||
Vaninder K Dhillon | |||
P2860 | cites work | EphB4 expression and biological significance in prostate cancer | Q24304334 |
Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4 | Q24336334 | ||
A comprehensive pathway map of epidermal growth factor receptor signaling | Q24672490 | ||
Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development | Q28145776 | ||
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer | Q28262641 | ||
Ephrins and Eph receptors in stem cells and cancer | Q28292229 | ||
Ephrin signaling in vivo: look both ways | Q28296703 | ||
Bidirectional Eph-ephrin signaling during axon guidance | Q28297294 | ||
Regulation of angiogenesis by Eph-ephrin interactions | Q28306625 | ||
EGF receptor | Q28646107 | ||
Eph-ephrin bidirectional signaling in physiology and disease | Q29617975 | ||
Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. | Q33256258 | ||
Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1. | Q33737243 | ||
Eph receptors and ephrins in cancer: bidirectional signalling and beyond | Q34021365 | ||
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis | Q34022315 | ||
P53 mutations in thyroid carcinoma: tidings from an old foe. | Q34338919 | ||
EGFR and cancer prognosis | Q34399312 | ||
Inhibition of tumor growth and angiogenesis by soluble EphB4. | Q34770033 | ||
RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR. | Q35124840 | ||
Receptor tyrosine kinase EphB4 is a survival factor in breast cancer | Q35221906 | ||
How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy | Q35942401 | ||
Prognostic impact of EGF-receptor in papillary thyroid carcinoma | Q35977349 | ||
Pathogenetic mechanisms in thyroid follicular-cell neoplasia | Q36430189 | ||
Paradoxes of the EphB4 receptor in cancer | Q36812751 | ||
Identification of potential therapeutic targets in human head & neck squamous cell carcinoma | Q37285806 | ||
Molecular pathology of thyroid cancer: diagnostic and clinical implications | Q37337504 | ||
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth | Q37682093 | ||
Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis | Q37980407 | ||
EphB4 is overexpressed in papillary thyroid carcinoma and promotes the migration of papillary thyroid cancer cells | Q39359780 | ||
EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration | Q39602928 | ||
The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma | Q40046746 | ||
EphB4 provides survival advantage to squamous cell carcinoma of the head and neck | Q40292503 | ||
Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells. | Q40670502 | ||
Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. | Q41098136 | ||
Epidermal growth factor stimulates cell proliferation and inhibits iodide uptake of FRTL-5 cells in vitro | Q41340452 | ||
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis | Q43072819 | ||
Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. | Q45958891 | ||
Automated selection of DAB-labeled tissue for immunohistochemical quantification. | Q50494832 | ||
Co-expression of the genes encoding transforming growth factor-α and its receptor in papillary carcinomas of the thyroid | Q53505149 | ||
Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation. | Q53675468 | ||
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. | Q54398600 | ||
The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma. | Q54576061 | ||
Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas | Q70824085 | ||
Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues | Q72328445 | ||
Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications | Q80567974 | ||
P433 | issue | 7 | |
P921 | main subject | papillary thyroid cancer | Q2292945 |
overexpression | Q61643320 | ||
P304 | page(s) | 964-969 | |
P577 | publication date | 2014-06-27 | |
P1433 | published in | Head & Neck | Q13703062 |
P1476 | title | Overexpression of EphB4, EphrinB2, and epidermal growth factor receptor in papillary thyroid carcinoma: A pilot study | |
P478 | volume | 37 |
Q47146373 | Eph-B4 regulates adaptive venous remodeling to improve arteriovenous fistula patency. |
Q41092476 | Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells |
Q43083986 | Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition |
Q58738086 | HMQ-T-B10 induces human liver cell apoptosis by competitively targeting EphrinB2 and regulating its pathway |
Q64986508 | High serum Ephrin-B2 levels predict poor prognosis for patients with gastric cancer. |
Q36352337 | Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway |
Q36262217 | MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells |
Q33599430 | Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma |
Q37723106 | The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer |
Q53157139 | Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations. |
Search more.